CureVac (NASDAQ: CVAC)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.530 | -0.090 | 0.4400 | ||||
REV | 27.360M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of CureVac (NASDAQ: CVAC) through any online brokerage.
There are no as such competitors for CureVac.
The latest price target for CureVac (NASDAQ: CVAC) was reported by JMP Securities on Friday, April 22, 2022. The analyst firm set a price target for 37.00 expecting CVAC to rise to within 12 months (a possible 159.83% upside). 4 analyst firms have reported ratings in the last year.
The stock price for CureVac (NASDAQ: CVAC) is $14.24 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for CureVac.
CureVac’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for CureVac.
CureVac is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.